Mithra and Searchlight Pharma Announce Nextstellis® Approval in Canada
Mithra Logo (CNW Group/Searchlight Pharma Inc.) First E4-based product approved internationally Canadian regulatory approval is the first in the world for the novel combined oral contraceptive Nextstellis ® Approval supported by two large multinational Phase 3 studies conducted in 3,725 women Commercial launch in Canada anticipated mid-summer 2021 LIEGE, Belgium and MONTREAL, March 8, 2021 /CNW/ - Mithra and Searchlight Pharma announced today that Health Canada has approved Nextstellis ®, the first and only combined oral contraceptive (COC) product based on the unique native estrogen est...